The aim of this study was to look for trends in demography and treatment of patients with both heart failure (HF) with preserved and reduced ejection fraction (EF) and to establish the extent of adherence to ESC guidelines for heart failure treatment.
Materials and Methods: This is a retrospective study involving 535 heart failure patients hospitalized for the period from January 2010 to December 2014. It involves age, gender, left ventricular EF, drug treatment prohibiting comorbidities and medical treatment with renin-angiotensin system blockers, beta- blockers and mineralocorticoid receptor antagonists.
Results: Patients in general tended to become older, and females and HFrEF to be prevalent over time in the investigated period. Patients with HF with preserved EF (HFpEF) were older than those with reduced EF. Male gender prevailed in the group of patients with HF with reduced EF (HFrEF) and female – among those with HFpEF. When estimating the annual percentage of non-adherence to therapy recommendations for heart failure, taking into account contraindications as well, a trend to better adherence to treatment recommendations over time was found. Still, there was a high percentage of non-adherence to heart failure therapy recommendations for both HFpEF and HFrEF.
Conclusion: There was increasing predominance of HFpEF, older age and female gender in heart failure hospitalizations over time with a tendency to improve adherence to ESC recommended treatments for heart failure in 2010-2014.